The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Intra-Cellular Therapies Inc shares valued at $2,628,450 were purchased by ALEXANDRIA VENTURE INVESTMENTS on Mar 18 ’25. At $131.42 per share, ALEXANDRIA VENTURE INVESTMENTS acquired 20,000 shares.
Also, ALEXANDRIA VENTURE INVESTMENTS purchased 11,750 shares, netting a total of over 1,544,292 in proceeds.
Before that, Mates Sharon had sold 51,000 shares from its account. In a trade valued at $4,375,659, the Chairman and CEO traded Intra-Cellular Therapies Inc shares for $85.80 each. Upon closing the transaction, the insider’s holdings decreased to 51,000 shares, worth approximately $140.86 million.
As published in a research note from Mizuho on February 24, 2025, Intra-Cellular Therapies Inc [ITCI] has been rated down from an Outperform to a Neutral and the price target has been revised to $132 from $140. Analysts at Canaccord Genuity downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late January. As of September 06, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for ITCI. Earlier on January 03, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for ITCI stock.
Analyzing ITCI Stock Performance
During the last five days, there has been a surge of approximately 0.18%. Over the course of the year, Intra-Cellular Therapies Inc shares have jumped approximately 57.57%. Shares of the company reached a 52-week high of $131.60 on 03/20/25 and a 52-week low of $80.82 on 01/07/25. A 50-day SMA is recorded $126.11, while a 200-day SMA reached $89.81.
Support And Resistance Levels for Intra-Cellular Therapies Inc (ITCI)
According to the 24-hour chart, there is a support level at 131.53, which, if violated, would cause prices to drop to 131.47. In the upper region, resistance lies at 131.63. The next price resistance is at 131.67. RSI (Relative Strength Index) is 84.87 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.20, which suggests the price will decrease in the coming days. Percent R is at 0.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
